Rhenman & Partners Asset Management AB - JUNO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$5,002,000
+11.5%
109,430
+9.4%
0.68%
+18.0%
Q3 2017$4,486,000–100,000–0.57%–
 Download
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders